Novartis
Director, Product Strategy Lead, Urology/Prostate
Novartis, East Hanover, New Jersey, us, 07936
Summary
The Director, Product Strategy Lead, Urology/Prostate will be responsible for identifying strategic opportunities in the US Urology market to further Novartis’ leadership in prostate cancer. This role will deliver initial cross-functional US launch strategies/initiatives required to prepare the urology market and the organization for first-class commercial launches, maximize impact and drive adoption through targeted, strategic engagement of urology-specific organizations and networks, including community-based LUGPAs, GPOs, and private equity-owned urology networks. This role will also execute above-indication strategic projects that will drive sustained leadership in the disease area, including developing Novartis’ vision and strategy for closing gaps in health equity in prostate cancer in the US and early identification of key competitive and other market trends, building responses to ensure Novartis is optimally placed to navigate these.
About the Role
Key Responsibilities:
In collaboration with Lifecycle Management leads, champion US commercial interests at respective GPTs regarding decisions impacting indications/assets in scope.
Support Executive Director, PSL, Prostate with prioritization of projects across the prostate portfolio based on available resources and anticipated impact within the urology setting, including identifying opportunities for efficiency improvements specifically tailored to urology practices and networks. Monitor and analyze the evolving treatment and competitive landscape as it applies to urology practices, including monitoring treatment outcomes and treatment decisions identifying trends related to various treatment modalities.
Cultivate and maintain strategic relationships with key opinion leaders (KOLs) in community urology in order to identify educational needs, strategic opportunities, and gaps that may affect treatment adoption and market penetration in the urology setting. Conduct insight-generation workstreams (research, advisory boards, data analyses, external thought leader engagements, other) to generate deep insights and become a subject matter expert on disease, key stakeholders, competitors, and unmet needs.
Input into and validate core assumptions within the Novartis prostate forecast, supporting refinement to ensure accuracy of predicted opportunity of indications/assets in scope.
Partner closely with Competitive Readiness to execute competitive benchmarking, conduct compliant competitive intelligence gathering, develop cross-functional competitive differentiation strategies, conduct scenario planning/simulations, and overall maintain a strategic point of view regarding key market trends and competitors for indications/assets in scope.
In collaboration with cross-functional teams (e.g., Clinical, Medical, Marketing, NPS, Market Access, PR/Comms, Regulatory), lead development of initial indication positioning, strategic imperatives, and pre-launch tactics for new indications/assets, ensuring close alignment with existing short (1-2 year) and longer-term (5+ years) prostate strategies. Assemble lean cross-functional launch teams and oversee the development of high-level launch roadmaps based on internal (Launch Excellence) and external best practices; lead reporting to senior management on progress.
Support integration of new prostate assets into urology-specific networks - strategically, tactically, logistically.
Lead/support delivery of above-indication strategic projects within prostate cancer beneficial to the portfolio, e.g., addressing health inequities within prostate cancer in the US, landscape assessments of relevant innovations within healthcare.
The ideal location for this role is East Hanover, NJ but remote work may be possible (there may be some restrictions based on legal entity). This position will require up to 20% travel as defined by the business (domestic and/or international).
What You’ll Bring to the Role:
Education:
Bachelor’s Degree in a relevant area is required
Essential Requirements:
7+ years in the pharmaceutical, biotech, healthcare, or healthcare consulting industry inclusive of at least 2 different types of cross-functional roles/experience.
US commercial launch and product lifecycle stages experience, ideally within prostate cancer or radioligand therapy.
Understanding of Urology-based practices and organizations in the US, including key factors that affect treatment adoption, guidelines, and operational influences.
2+ years of direct responsibility for large budget management.
Holds a network of both regionally and nationally influential KOLs in the Urology community.
Demonstrated strategic acumen plus strong analytical skills and an ability to generate insights and develop relevant action plans.
Strong ability to simplify complex concepts & strategies and “tell a story” verbally and in writing.
Strong influencing skills, and the ability to exercise tact and diplomacy in challenging situations.
Desirable requirements:
Global or other country region experience.
Master of Business Administration (MBA)
Commitment to Diversity & Inclusion:
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
The pay range for this position at commencement of employment is expected to be between $212,000 and $318,000/year; however, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including geographical location, experience level, knowledge, skills and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits.
EEO Statement:
The Novartis Group of Companies are Equal Opportunity Employers who are focused on building and advancing a culture of inclusion that values and celebrates individual differences, uniqueness, backgrounds and perspectives.
Accessibility & Reasonable Accommodations
The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities.
#J-18808-Ljbffr
The Director, Product Strategy Lead, Urology/Prostate will be responsible for identifying strategic opportunities in the US Urology market to further Novartis’ leadership in prostate cancer. This role will deliver initial cross-functional US launch strategies/initiatives required to prepare the urology market and the organization for first-class commercial launches, maximize impact and drive adoption through targeted, strategic engagement of urology-specific organizations and networks, including community-based LUGPAs, GPOs, and private equity-owned urology networks. This role will also execute above-indication strategic projects that will drive sustained leadership in the disease area, including developing Novartis’ vision and strategy for closing gaps in health equity in prostate cancer in the US and early identification of key competitive and other market trends, building responses to ensure Novartis is optimally placed to navigate these.
About the Role
Key Responsibilities:
In collaboration with Lifecycle Management leads, champion US commercial interests at respective GPTs regarding decisions impacting indications/assets in scope.
Support Executive Director, PSL, Prostate with prioritization of projects across the prostate portfolio based on available resources and anticipated impact within the urology setting, including identifying opportunities for efficiency improvements specifically tailored to urology practices and networks. Monitor and analyze the evolving treatment and competitive landscape as it applies to urology practices, including monitoring treatment outcomes and treatment decisions identifying trends related to various treatment modalities.
Cultivate and maintain strategic relationships with key opinion leaders (KOLs) in community urology in order to identify educational needs, strategic opportunities, and gaps that may affect treatment adoption and market penetration in the urology setting. Conduct insight-generation workstreams (research, advisory boards, data analyses, external thought leader engagements, other) to generate deep insights and become a subject matter expert on disease, key stakeholders, competitors, and unmet needs.
Input into and validate core assumptions within the Novartis prostate forecast, supporting refinement to ensure accuracy of predicted opportunity of indications/assets in scope.
Partner closely with Competitive Readiness to execute competitive benchmarking, conduct compliant competitive intelligence gathering, develop cross-functional competitive differentiation strategies, conduct scenario planning/simulations, and overall maintain a strategic point of view regarding key market trends and competitors for indications/assets in scope.
In collaboration with cross-functional teams (e.g., Clinical, Medical, Marketing, NPS, Market Access, PR/Comms, Regulatory), lead development of initial indication positioning, strategic imperatives, and pre-launch tactics for new indications/assets, ensuring close alignment with existing short (1-2 year) and longer-term (5+ years) prostate strategies. Assemble lean cross-functional launch teams and oversee the development of high-level launch roadmaps based on internal (Launch Excellence) and external best practices; lead reporting to senior management on progress.
Support integration of new prostate assets into urology-specific networks - strategically, tactically, logistically.
Lead/support delivery of above-indication strategic projects within prostate cancer beneficial to the portfolio, e.g., addressing health inequities within prostate cancer in the US, landscape assessments of relevant innovations within healthcare.
The ideal location for this role is East Hanover, NJ but remote work may be possible (there may be some restrictions based on legal entity). This position will require up to 20% travel as defined by the business (domestic and/or international).
What You’ll Bring to the Role:
Education:
Bachelor’s Degree in a relevant area is required
Essential Requirements:
7+ years in the pharmaceutical, biotech, healthcare, or healthcare consulting industry inclusive of at least 2 different types of cross-functional roles/experience.
US commercial launch and product lifecycle stages experience, ideally within prostate cancer or radioligand therapy.
Understanding of Urology-based practices and organizations in the US, including key factors that affect treatment adoption, guidelines, and operational influences.
2+ years of direct responsibility for large budget management.
Holds a network of both regionally and nationally influential KOLs in the Urology community.
Demonstrated strategic acumen plus strong analytical skills and an ability to generate insights and develop relevant action plans.
Strong ability to simplify complex concepts & strategies and “tell a story” verbally and in writing.
Strong influencing skills, and the ability to exercise tact and diplomacy in challenging situations.
Desirable requirements:
Global or other country region experience.
Master of Business Administration (MBA)
Commitment to Diversity & Inclusion:
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
The pay range for this position at commencement of employment is expected to be between $212,000 and $318,000/year; however, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including geographical location, experience level, knowledge, skills and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits.
EEO Statement:
The Novartis Group of Companies are Equal Opportunity Employers who are focused on building and advancing a culture of inclusion that values and celebrates individual differences, uniqueness, backgrounds and perspectives.
Accessibility & Reasonable Accommodations
The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities.
#J-18808-Ljbffr